Table 2. Examples of Studies Reporting Carbapenemases in Pseudomonas aeruginosa since 2020.
| Ambler class | Carbapenemase | Source of Isolation | Country | Year | Reference |
| A | KPC-2 | Ascitic fluid | Brazil | 2021 | [63] |
| KPC-2 | Respiratory, surgical, and urine samples from ICU patients | China | 2021 | [64] | |
| KPC-90 | Fecal screening sample | China | 2022 | [65] | |
| GES-24 | Long-term care facilities | Korea | 2020 | [66] | |
|
| |||||
| B | VIM-5 | Various clinical isolates | Nigeria | 2021 | [67] |
| VIM | Various clinical isolates | Malaysia | 2021 | [68] | |
| VIM-1, VIM-2, VIM-4 | Clinical and screening specimens from critical care units | Germany | 2022 | [69] | |
| VIM-6 | Various clinical samples | Kenya | 2022 | [70] | |
| IMP-1, IMP-7, IMP-10, IMP-34, IMP-41 | Various clinical samples | Japan | 2022 | [71] | |
| IMP-6 | Urine | Korea | 2022 | [72] | |
| NDM-1 | Sputum or endotracheal aspirates of COVID-19 patients | Egypt | 2020 | [73] | |
| NDM-1 | Clinical and screening specimens from critical care units | Germany | 2022 | [69] | |
| NDM-1 | Various clinical samples | Kenya | 2022 | [70] | |
| NDM-1 | Urine | Korea | 2022 | [72] | |
|
| |||||
| D | OXA-913 | Skin specimen of a dog with pyoderma | Korea | 2021 | [74] |
| OXA-486 | Feces of a red deer sampled in a humanized area | Portugal | 2022 | [75] | |